FI914898A0 - Leverspecifika insulinanaloger. - Google Patents

Leverspecifika insulinanaloger.

Info

Publication number
FI914898A0
FI914898A0 FI914898A FI914898A FI914898A0 FI 914898 A0 FI914898 A0 FI 914898A0 FI 914898 A FI914898 A FI 914898A FI 914898 A FI914898 A FI 914898A FI 914898 A0 FI914898 A0 FI 914898A0
Authority
FI
Finland
Prior art keywords
leverspecifika
insulinanaloger
insulin analogues
hepatospecific
insulin
Prior art date
Application number
FI914898A
Other languages
English (en)
Finnish (fi)
Inventor
Panayotis G Katsoyannis
Original Assignee
Sinai School Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinai School Medicine filed Critical Sinai School Medicine
Publication of FI914898A0 publication Critical patent/FI914898A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
FI914898A 1989-04-20 1991-10-17 Leverspecifika insulinanaloger. FI914898A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34092989A 1989-04-20 1989-04-20
PCT/US1990/002070 WO1990012814A1 (en) 1989-04-20 1990-04-17 Hepatospecific insulin analogues

Publications (1)

Publication Number Publication Date
FI914898A0 true FI914898A0 (fi) 1991-10-17

Family

ID=23335524

Family Applications (1)

Application Number Title Priority Date Filing Date
FI914898A FI914898A0 (fi) 1989-04-20 1991-10-17 Leverspecifika insulinanaloger.

Country Status (15)

Country Link
EP (1) EP0469084B1 (pt)
JP (1) JPH04504858A (pt)
AT (1) ATE120762T1 (pt)
AU (1) AU631868B2 (pt)
CA (1) CA2014896A1 (pt)
DE (1) DE69018461T2 (pt)
FI (1) FI914898A0 (pt)
GR (1) GR1000908B (pt)
HU (1) HU210142B (pt)
IE (1) IE67353B1 (pt)
IL (1) IL94163A (pt)
NO (1) NO301544B1 (pt)
PT (1) PT93832B (pt)
WO (1) WO1990012814A1 (pt)
ZA (1) ZA902965B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK158390D0 (da) * 1990-07-02 1990-07-02 Novo Nordisk As Nye peptider
DK33591D0 (pt) * 1991-02-27 1991-02-27 Novo Nordisk As
US5268453A (en) * 1991-08-08 1993-12-07 Scios Inc. Tissue-selective insulin analogs
GB9316895D0 (en) * 1993-08-13 1993-09-29 Guy S And St Thomas Hospitals Hepatoselective insulin analogues
US5915378A (en) * 1993-01-29 1999-06-29 Aradigm Corporation Creating an aerosolized formulation of insulin
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US5888477A (en) * 1993-01-29 1999-03-30 Aradigm Corporation Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
US5970973A (en) * 1993-01-29 1999-10-26 Aradigm Corporation Method of delivering insulin lispro
US6024090A (en) 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
US5743250A (en) * 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
US5873358A (en) * 1993-01-29 1999-02-23 Aradigm Corporation Method of maintaining a diabetic patient's blood glucose level in a desired range
TW404844B (en) * 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
US6342225B1 (en) 1993-08-13 2002-01-29 Deutshces Wollforschungsinstitut Pharmaceutical active conjugates
US6933272B1 (en) 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
AUPP609198A0 (en) * 1998-09-22 1998-10-15 Curtin University Of Technology Use of non-peptidyl compounds for the treatment of insulin related ailments
US7375085B1 (en) 1999-04-26 2008-05-20 Ajinomoto Co., Inc. Melanocyte-stimulating hormone inhibitors
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
WO2006019015A1 (ja) * 2004-08-18 2006-02-23 Kaneka Corporation インスリン結合たんぱく質と結合能力のあるペプチドおよび吸着材
ES2368500T3 (es) 2005-08-16 2011-11-17 Novo Nordisk A/S Método para producir polipéptidos de insulina maduros.
KR101699370B1 (ko) 2006-09-22 2017-02-14 노보 노르디스크 에이/에스 프로테아제 내성 인슐린 유사체
ES2464282T3 (es) 2006-09-27 2014-06-02 Novo Nordisk A/S Método para preparar polipéptidos de insulina madura
WO2009099763A1 (en) 2008-01-30 2009-08-13 Indiana University Research And Technology Corporation Ester-based peptide prodrugs
JP5762001B2 (ja) 2008-03-14 2015-08-12 ノボ・ノルデイスク・エー／エス プロテアーゼ安定化インスリンアナログ
EP2910569B1 (en) 2008-03-18 2016-10-05 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
US20110294729A1 (en) * 2008-12-09 2011-12-01 Novo Nordisk A/S Novel Insulin Analogues
EP2376520B1 (en) 2008-12-19 2014-02-12 Indiana University Research&Technology Corporation Insulin analogs
CA2744558A1 (en) * 2008-12-19 2010-07-15 Indiana University Research And Technology Corporation Amide-based insulin prodrugs
CA2802485C (en) 2010-06-16 2019-09-17 Indiana University Research And Technology Corporation Single chain insulin agonists exhibiting high activity at the insulin receptor
CA2803164C (en) 2010-06-24 2018-08-21 Indiana University Research And Technology Corporation Amide-based insulin prodrugs
US9573987B2 (en) 2011-12-20 2017-02-21 Indiana University Research And Technology Corporation CTP-based insulin analogs for treatment of diabetes
CN104981251B (zh) 2012-09-26 2018-03-20 印第安纳大学研究及科技有限公司 胰岛素类似物二聚体
EP2970511B1 (en) 2013-03-14 2020-09-30 Indiana University Research and Technology Corporation Insulin-incretin conjugates
JP6410790B2 (ja) 2013-03-14 2018-10-24 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー ミトコンドリアアルデヒドデヒドロゲナーゼ−２調節因子およびその使用方法
BR112016007166A2 (pt) 2013-10-07 2017-09-12 Novo Nordisk As derivado de um análogo de insulina
JP6701208B2 (ja) 2014-09-24 2020-05-27 インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション 脂質化アミド系インスリンプロドラッグ
US10232020B2 (en) 2014-09-24 2019-03-19 Indiana University Research And Technology Corporation Incretin-insulin conjugates
JP6690062B2 (ja) 2016-12-16 2020-04-28 ノヴォ ノルディスク アー／エス インスリン含有医薬組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation

Also Published As

Publication number Publication date
EP0469084A1 (en) 1992-02-05
DE69018461D1 (de) 1995-05-11
IL94163A (en) 1995-08-31
IE901404L (en) 1990-10-20
GR900100290A (en) 1991-09-27
DE69018461T2 (de) 1995-08-03
HU903398D0 (en) 1991-12-30
NO301544B1 (no) 1997-11-10
PT93832A (pt) 1990-11-20
ATE120762T1 (de) 1995-04-15
AU5541590A (en) 1990-11-16
AU631868B2 (en) 1992-12-10
GR1000908B (el) 1993-03-16
NO914085L (no) 1991-11-28
HUT59941A (en) 1992-07-28
JPH04504858A (ja) 1992-08-27
EP0469084B1 (en) 1995-04-05
ZA902965B (en) 1991-02-27
IL94163A0 (en) 1991-01-31
PT93832B (pt) 1996-09-30
CA2014896A1 (en) 1990-10-20
WO1990012814A1 (en) 1990-11-01
HU210142B (en) 1995-02-28
NO914085D0 (no) 1991-10-17
IE67353B1 (en) 1996-03-20

Similar Documents

Publication Publication Date Title
FI914898A0 (fi) Leverspecifika insulinanaloger.
ES552093A0 (es) Un procedimiento para sintetizar una secuencia de aminoacidos que contienen la totalidad o parte de la secuencia de aminoacidos de la preprorrelaxina -h2 humana.
NZ506447A (en) Peptide analogues of insulin with alanine substitutions and pharmaceutical use
ATE104348T1 (de) O-glycosyliertes ifn-alpha.
DE68908300D1 (de) Patch fuer eingeweidechirurgie.
ES2174770T1 (es) Peptidos diseñados para el diagnostico y el tratamiento de artritis reumatoide.
IS1966B (is) Peptíð p277 hliðstæður og lyfjasamsetningar sem innihalda þær, til meðhöndlunar eða sjúkdómsgreiningar á sykursýki
ES2103854T3 (es) Peptidos con actividad organo protectiva, procedimiento para la preparacion de los mismos y su utilizacion en la terapia.
PT88086A (pt) Processo para a preparacao de composicoes farmaceuticas a base de sais de alfa-aminoacidos basicos e de alfa-ceto-analogos de aminoacidos de cadeia ramificada apropriadas para o tratamento da uremia
MX24890A (es) Polipeptido sintetico, procedimiento par su preparacion y composicion farmaceutica que lo contiene.
SE7501342L (pt)
FI942392A (fi) Peptidejä ja vasta-aineita nivelreuman hoitoon
ES517596A0 (es) Procedimiento para la preparacion de un peptido.
DK0717048T3 (da) Cyclohexapeptider og deres blandinger, fremgangsmåde til fremstilling deraf samt deres anvendelse
DE59107762D1 (de) Komplexe, enthaltend S(+)-Phenyl-alkansäuren und alpha-Hydroxy-alkansäuren
EP0248231A3 (en) Pharmacologically active peptides
PT99850A (pt) Processo para a preparacao de novos peptideos com efeito insulinico
DK180290A (da) Monoxidil-gel og fremgangsmaade til fremstilling deraf
ATE112290T1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
DK0423326T3 (da) Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta
DK119391A (da) Humaninsulinanaloger
ES521569A0 (es) Un procedimiento para obtener una composicion farmaceutica liofilizada a base de interferon y un aminoacido estabilizante.
DK369888A (da) Peptidforbindelser